NBI-1070770
- Generic Name
- NBI-1070770
A Study to Evaluate the Efficacy and Safety of NBI-1070770 in Adults With Major Depressive Disorder
- First Posted Date
- 2024-02-20
- Last Posted Date
- 2025-02-28
- Lead Sponsor
- Neurocrine Biosciences
- Target Recruit Count
- 72
- Registration Number
- NCT06267846
- Locations
- 🇺🇸
Neurocrine Clinical Site, Richardson, Texas, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath